BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/21/2025 10:12:48 AM | Browse: 39 | Download: 92
 |
Received |
|
2024-08-14 02:39 |
|
Peer-Review Started |
|
2024-06-27 15:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-19 22:01 |
|
Revised |
|
2024-10-03 17:10 |
|
Second Decision |
|
2024-11-07 02:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-11-07 09:34 |
|
Articles in Press |
|
2024-11-07 09:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-11-21 19:08 |
|
Typeset the Manuscript |
|
2024-11-28 07:59 |
|
Publish the Manuscript Online |
|
2025-02-21 10:12 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Theodoros Pettas, Sofia Lachanoudi, Filippos F Karageorgos, Ioannis A Ziogas, Asimina Fylaktou, Vassilios Papalois, Georgios Katsanos, Nikolaos Antoniadis and Georgios Tsoulfas |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Georgios Tsoulfas, MD, PhD, Professor, Department of Transplantation Surgery, Center for Research and Innovation in Solid Organ Transplantation, Aristotle University of Thessaloniki, School of Medicine, 49 Konstantinoupoleos Street, Thessaloniki 54642, Greece. tsoulfasg@gmail.com |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Liver transplantation; Neoadjuvant and adjuvant immunotherapy; Immune checkpoint inhibitors; Vaccine therapies; Oncolytic viruses; Adoptive cell therapy; Antigen-targeting antibodies; Diagnostic biomarkers |
| Core Tip |
Hepatocellular carcinoma is a prevalent condition nowadays. The increasing number of new cases worldwide requires intensive research and innovative curative options. Cancer immunotherapy constitutes a constantly growing field in terms of treatment of the disease, as well as potential tumor downstaging with an eye to liver transplantation. There are two approaches regarding immunotherapy for hepatocellular carcinoma: Boosting the existing immune response and stimulating the de novo immune response. |
| Publish Date |
2025-02-21 10:12 |
| Citation |
<p>Pettas T, Lachanoudi S, Karageorgos FF, Ziogas IA, Fylaktou A, Papalois V, Katsanos G, Antoniadis N, Tsoulfas G. Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges. <i>World J Transplant</i> 2025; 15(2): 98509</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v15/i2/98509.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v15.i2.98509 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
